Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT) [Phase 3]
Phase 3 trial evaluating dupilumab for moderate-to-severe atopic hand and foot dermatitis has completed with posted results.
-
FDA approval · 2023-12-14FDA Approved: ADBRY — Supplemental Application (LEO Pharma Inc.)
FDA approved a supplemental application for ADBRY (tralokinumab-ldrm) by LEO Pharma Inc., indicating a change to labeling or indication.
-
FDA approval · 2023-12-14FDA Approved: CIBINQO — Supplemental Application (U.S. Pharmaceuticals)
FDA approved a supplemental application for CIBINQO (abrocitinib) filed by U.S. Pharmaceuticals.
-
FDA approval · 2023-12-14FDA Approved: CYCLOSPORINE — Original Application (Teva Pharmaceuticals, Inc.)
FDA approves Teva Pharmaceuticals' generic cyclosporine under an original application (ANDA 203880), expanding access to this immunosuppress…
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis (AD) [Phase 1, Phase 2]
A Phase 1/2 study of AR100DP1 in mild to moderate atopic dermatitis was terminated with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of CBP-201 in Chinese adults with moderate to severe atopic dermatitis.
-
FDA approval · 2023-12-05FDA Approved: PREDNISONE TABLETS, USP, 5 MG — Supplemental Application (Granulation Technology, Inc.)
FDA granted a supplemental approval for Prednisone Tablets, USP, 5 mg to authorize a granulation technology manufacturing change by Granulat…
-
FDA approval · 2023-11-29FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's supplemental application for clobetasol propionate, a potent topical corticosteroid, enabling an approved supplement…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: The Effectiveness of a Topical Palmitoylethanolamide (PEA) Formulation (Levagen+) for Reducing Symptoms of Eczema [Phase 2, Phase 3]
A phase 2/3 trial evaluating a topical palmitoylethanolamide (Levagen+) formulation for reducing symptoms of atopic dermatitis (eczema) has …
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel [Phase 2]
Phase 2 trial comparing DBI-001 Gel to aqueous gel in atopic dermatitis was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update for CM310 in moderate-to-severe atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: The Purpose of the Study is to Evaluate the Effect of Ruxolitinib Cream on Itch in Participants With Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating the effect of Ruxolitinib Cream on itch in participants with atopic dermatitis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: HPA Axis Study in Adults [Phase 2]
Phase 2 clinical trial update on HPA axis study in adults evaluated for Atopic Dermatitis and Eczema; study completed.
-
CLINICAL_TRIALS trial_result · 2023-10-27Clinical Trial Update: A Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update for LNK01001 capsule in moderate-to-severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis [Phase 2]
Phase 2 trial updating the study of bran-brutinib (BMS-986166) for atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: Open-label Study of Dupilumab in Patients With Atopic Dermatitis [Phase 3]
Open-label Phase 3 trial investigating dupilumab in patients with atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis [Phase 4]
Phase 4 clinical trial update evaluating dupilumab in pediatric patients with atopic dermatitis, focusing on skin barrier function and lipid…
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Comparative Study:Topison (Mometasone Furoate) Versus Two Others Mometasone Furoates [Phase 4]
Phase 4 comparative trial update evaluating Topison (Mometasone Furoate) against two other mometasone formulations for atopic dermatitis; st…
-
FDA approval · 2023-10-10FDA Approved: TACROLIMUS — Original Application (Encube Ethicals, Inc.)
FDA approved Encube Ethicals, Inc.'s tacrolimus ointment 0.1% as a generic product for the treatment of atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update for ATI-1777 in adults with moderate to severe atopic dermatitis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis [Phase 2]
Phase 2 trial results for MEDI3506 in adults with atopic dermatitis have been completed and posted.
-
CLINICAL_TRIALS withdrawal · 2023-09-21Clinical Trial Update: Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to or for Whom Cyclosporine A is Not Medically Advisable [Phase 3]
Phase 3 clinical trial of nemolizumab in moderate-to-severe atopic dermatitis with inadequate response to cyclosporine A or for whom cyclosp…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: HPA Axis Study in Japanese Adults [Phase 2]
Phase 2 clinical trial update evaluating HPA axis effects in Japanese adults with atopic dermatitis/eczema has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 long-term safety study of ASN002 in moderate to severe atopic dermatitis was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic Dermatitis [Phase 2]
Phase 2 clinical trial evaluating safety, tolerability, and efficacy of ZEP-3Na at two concentrations versus placebo in mild to moderate ato…